新疗法增长驱动
Search documents
Repligen (NasdaqGS:RGEN) FY Conference Transcript
2025-12-03 19:22
Repligen (NasdaqGS:RGEN) FY Conference December 03, 2025 01:20 PM ET Company ParticipantsStephen Shah - Head of Investor RelationsJason Garland - CFOConference Call ParticipantsDaniel Markowitz - AnalystDaniel MarkowitzAre we live? Great. Awesome. Thank you, everyone, for joining. For those of you who don't know me, I'm Daniel Markowitz. I cover the life science, tools, and diagnostics and med tech space here at Evercore ISI. Today we're joined by Repligen. We have with us CFO Jason Garland and, from Invest ...